Doctor profile · Federal record
Dr. Jaffar Hilli, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Columbia, MO
- NPI 1952657462
- Accepts Medicare
- 27 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
One Hospital Drive
Columbia, MO 652120001
(573) 882-8445
fax (573) 884-7822 - Mailing address
-
Po Box 843966
Kansas City, MO 641843966
Credentials & registration
- NPI registered
- August 2012 — 14 yrs on file
- Profile last updated
- October 2, 2025
- Year of graduation
- 1999 — 27 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Florida #ME171475
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1952657462. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
195,843
Distinct HCPCS
10
Medicare allowed
$1,999,890
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 98,250 | 62 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 22,000 | 17 | $48 | |
J1453 |
Injection, fosaprepitant, 1 mg | 17,100 | 30 | $0 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 11,220 | 13 | $1 | |
J9267 |
Injection, paclitaxel, 1 mg | 10,150 | 14 | $0 | |
J1306 |
Injection, inclisiran, 1 mg | 8,520 | 17 | $12 | |
J0897 |
Injection, denosumab, 1 mg | 6,720 | 44 | $23 | |
Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 3,681 | 16 | $8 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,948 | 50 | $0 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 2,049 | 27 | $0 |
In context: peer comparison
Among 9 peers in this city , average services per provider: 3,643. This provider delivers 54× the peer median.Open Payments
Industry payments received
All-time total
$535
Transactions
19
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Celgene Corporation | 2 | $80.60 | |
| PFIZER INC. | 3 | $66.28 | |
| Novartis Pharmaceuticals Corporation | 2 | $55.95 | |
| TAIHO ONCOLOGY, INC. | 1 | $38.72 | |
| UCB, Inc. | 1 | $37.26 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $32.09 | |
| ARRAY BIOPHARMA INC | 1 | $28.28 | |
| Lilly USA, LLC | 1 | $26.50 | |
| Telix Pharmaceuticals | 1 | $25.19 | |
| Gilead Sciences, Inc. | 1 | $25.11 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $23.23 | |
| Daiichi Sankyo Inc. | 1 | $21.71 | |
| ImmunoGen, Inc. | 1 | $20.57 | |
| ADC Therapeutics America, Inc. | 1 | $19.24 | |
| GlaxoSmithKline, LLC. | 1 | $19.05 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,125
Patients
386
Total drug cost
$779,694
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 241 | 79 | $6,694 |
| Dexamethasone | Generic | 122 | 63 | $1,741 |
| Prednisone | Generic | 104 | 29 | $799 |
| Ondansetron Hcl | Generic | 101 | 45 | $1,500 |
| Prochlorperazine Maleate | Generic | 94 | 58 | $1,723 |
| Olanzapine | Generic | 67 | 40 | $1,524 |
| Abiraterone Acetate | Generic | 65 | 0 | $162,441 |
| Potassium Chloride | Generic | 61 | 26 | $461 |
| Letrozole | Generic | 51 | 17 | $1,801 |
| Eliquis (Apixaban) | Brand | 48 | 0 | $38,115 |
Hospital affiliations
Frequently asked questions
What is Dr. Jaffar Hilli's medical specialty?
Dr. Jaffar Hilli practices Hematology & Oncology Physician in Columbia, MO.
Where does Dr. Jaffar Hilli practice?
Dr. Jaffar Hilli practices at One Hospital Drive, Columbia, MO 652120001. Office phone: 5738828445.
What is Dr. Jaffar Hilli's NPI?
Dr. Jaffar Hilli's National Provider Identifier (NPI) is 1952657462, issued by NPPES.
Does Dr. Jaffar Hilli accept Medicare assignment?
Yes. Dr. Jaffar Hilli accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jaffar Hilli commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.